116 related articles for article (PubMed ID: 435362)
1. Carcinoembryonic antigen in serum of unselected breast-cancer patients and of non-hospitalized controls.
Rimsten A; Adami HO; Wahren B; Nordin B
Br J Cancer; 1979 Feb; 39(2):109-15. PubMed ID: 435362
[TBL] [Abstract][Full Text] [Related]
2. Serum carcinoembryonic antigen in the diagnosis and prognosis of women with breast cancer.
Wang DY; Knyba RE; Bulbrook RD; Millis RR; Hayward JL
Eur J Cancer Clin Oncol; 1984 Jan; 20(1):25-31. PubMed ID: 6537913
[TBL] [Abstract][Full Text] [Related]
3. Serial carcinoembryonic antigen (CEA) determinations in the management of metastatic breast cancer.
Lamerz R; Leonhardt A; Ehrhart H; von Lieven H
Oncodev Biol Med; 1980; 1(2):123-35. PubMed ID: 7279699
[TBL] [Abstract][Full Text] [Related]
4. Carcinoembryonic-like substance in breast fluid discharge in benign and malignant breast disease and in milk of lactating women.
Kahana L; Bartal AH; Yechieli H; Guttman I; Sheinfeld M
Isr J Med Sci; 1981 Nov; 17(11):1035-40. PubMed ID: 7319791
[TBL] [Abstract][Full Text] [Related]
5. A direct competitive binding radioimmunoassay for carcinoembryonic antigen.
Fritsche HA; Tashima CK; Collinsworth WL; Geitner A; Van Oort J
J Immunol Methods; 1980; 35(1-2):115-28. PubMed ID: 7204983
[TBL] [Abstract][Full Text] [Related]
6. Biological markers in breast carcinoma. III. Clinical correlations with carcinoembryonic antigen.
Tormey DC; Waalkes TP; Snyder JJ; Simon RM
Cancer; 1977 Jun; 39(6):2397-404. PubMed ID: 872038
[TBL] [Abstract][Full Text] [Related]
7. Demonstration of elevated anti-Lewis antibodies in sera of cancer patients using a carcinoembryonic antigen-polyethylene glycol immunoassay.
Pompecki R; Shively JE; Todd CW
Cancer Res; 1981 May; 41(5):1910-5. PubMed ID: 6163531
[TBL] [Abstract][Full Text] [Related]
8. Carcinoembryonic antigen estimation in nipple discharge as an adjunctive tool in the diagnosis of early breast cancer.
Inaji H; Yayoi E; Maeura Y; Matsuura N; Tominaga S; Koyama H; Takatsuka Y; Mori T
Cancer; 1987 Dec; 60(12):3008-13. PubMed ID: 3677024
[TBL] [Abstract][Full Text] [Related]
9. [Tissue polypeptide and carcinoembryonic antigens in patients with breast cancer].
Polevaia EB; Tkacheva GA; Ivanov VM; Koposova TL
Vopr Onkol; 1984; 30(3):9-13. PubMed ID: 6710954
[TBL] [Abstract][Full Text] [Related]
10. [Our experience with the diagnostic and prognostic unreliability of pre- and postoperative CEA in human breast cancer].
Ovaleo-Pandolfo E; Capelli P; Franciosi V
Acta Biomed Ateneo Parmense; 1985; 56(2):91-8. PubMed ID: 2930984
[TBL] [Abstract][Full Text] [Related]
11. Human tissue polypeptide antigen in breast cancer.
Nemoto T; Constantine R; Chu TM
J Natl Cancer Inst; 1979 Dec; 63(6):1347-50. PubMed ID: 292806
[TBL] [Abstract][Full Text] [Related]
12. [Carcino-embryogenic antigen (CEA) in patients with genital tumors (author's transl)].
Anger H; Gleissenberger U
Geburtshilfe Frauenheilkd; 1977 Jul; 37(7):604-8. PubMed ID: 885332
[TBL] [Abstract][Full Text] [Related]
13. Occurrence of carcinoembryonic antigen in tumor tissue and serum of breast cancer patients.
Stratil P; Rejthar A; Lang BA; Kocent A; Pacovský Z; Matoska J
Neoplasma; 1988; 35(1):69-76. PubMed ID: 3352839
[TBL] [Abstract][Full Text] [Related]
14. [Radioimmunoassay of carcinoembryonic antigen in the evaluation of the effectiveness of breast cancer treatment].
Polevaia EB; Ivanov VM; Koposova TL; Gabuniia RI; Chinareva IV
Vopr Onkol; 1984; 30(4):23-9. PubMed ID: 6730403
[TBL] [Abstract][Full Text] [Related]
15. Serial carcinoembryonic antigen (CEA) determinations in the management of patients with breast cancer.
Staab HJ; Ahlemann LM; Koch HL; Anderer FA
Oncodev Biol Med; 1980; 1(3):151-60. PubMed ID: 7279702
[TBL] [Abstract][Full Text] [Related]
16. [Clinical evaluation of a new tumor marker, CA 15-3, in breast cancer; a comparative study with CEA].
Komuro K; Watanabe K; Ishida T; Sakurai M; Amano R; Hagiwara H; Hara Y; Hanzawa T; Itsubo K
Gan To Kagaku Ryoho; 1986 Oct; 13(11):3145-9. PubMed ID: 3465273
[TBL] [Abstract][Full Text] [Related]
17. Carcinoembryonic antigen: an invaluable marker for advanced breast cancer.
Pathak KA; Khanna R; Khanna HD; Khanna S; Gupta S; Khanna NN
J Postgrad Med; 1996; 42(3):68-71. PubMed ID: 9715319
[TBL] [Abstract][Full Text] [Related]
18. Targeting of human breast cancer by a bispecific antibody directed against two tumour-associated antigens: ErbB-2 and carcinoembryonic antigen.
Dorvillius M; Garambois V; Pourquier D; Gutowski M; Rouanet P; Mani JC; Pugnière M; Hynes NE; Pèlegrin A
Tumour Biol; 2002; 23(6):337-47. PubMed ID: 12677091
[TBL] [Abstract][Full Text] [Related]
19. Carcinoembryonic antigen and other tumor markers in tissue and serum or plasma of patients with primary mammary carcinoma.
Wahren B; Lidbrink E; Wallgren A; Eneroth P; Zajicek J
Cancer; 1978 Oct; 42(4):1870-8. PubMed ID: 361213
[TBL] [Abstract][Full Text] [Related]
20. Relation between ultrastructural presence of CEA using peroxidase-antiperoxidase (PAP) method and tissue and serum levels of CEA in patients with breast cancer.
Grzanka A; Cetnarowski L; Domaniewski J
Folia Histochem Cytobiol; 1991; 29(4):131-4. PubMed ID: 1819536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
